Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 28, 2024Population Health ManagementOpen Access

Use of a Blood Biomarker Test Improves Economic Utility in the Evaluation of Older Patients Presenting with Cognitive Impairment

View Full Paper
Ask AI
Bookmark
Share

Authors

WCWilliam J. CanestaroRBRandall J. BatemanDHDavid M. Holtzman

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Canestaro et al. (2024) studied this question.

synapsesocial.com/papers/68e71ecab6db643587698276https://doi.org/10.1089/pop.2023.0309
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cost-effectiveness analysis of blood-based biomarker testing in the diagnosis of Alzheimer’s disease pathology2026 · 3 citations
  2. 2Blood-based biomarkers and the current landscape of Alzheimer’s disease diagnosis: ethical considerations and practical guidance2026
  3. 3Cost-effectiveness of testing biofluid biomarkers to diagnose Alzheimer’s disease: a systematic review2025
  4. 4Implementation of an Alzheimer’s Disease Blood Test: Adoption Experience by Memory Care Specialists in a Multi-Center Study2025
  5. 5A blood biomarker test for brain amyloid impacts the clinical evaluation of cognitive impairment2023 · 34 citations